Zynerba Pharmaceuticals (ZYNE) Priced

Preclinical biotech developing transdermal cannabinoid-based therapies.

Health Care - Biotechnology

IPO Performance
Latest Trade $23.20 0.00 (0.0%)
First Day Return 16.1%
Return from IPO 65.7%
 
Zynerba Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 06/30/2015
Offer Price $14.00
Price Range $13.00 - $15.00
Offer Shares (mm) 3.0
Deal Size ($mm) 42
 
IPO Data
IPO Date 08/04/2015
Offer Price $14.00
Price Range $13.00 - $15.00
Offer Shares (mm) 3.0
Deal Size ($mm) $42
 
Underwriters
more
Business Overview
Preclinical biotech developing transdermal cannabinoid-based therapies.
Preclinical biotech developing transdermal cannabinoid-based therapies.
more
Company Data
Headquarters Devon, PA
Founded 2004
Employees 7
Website www.zynerba.com
 

Performance vs. IPO Index (IPOUSA)